Powering Prestige Experiences in Aesthetics with Products and Services Portfolio

The HintMD platform provides a seamless, simple and smart payment solution that empowers aesthetic practices to improve practice management, practice economics and practice loyalty.

Request a Demo

Acquisition provides Revance Aesthetics access to a $500M+ opportunity in U.S. aesthetic practice payment services

HintMD is now part of the Revance Aesthetics portfolio

Learn More

Acquisition provides Revance Aesthetics access to a $500M+ opportunity in U.S. aesthetic practice payment services

Products and Services

Disclaimers: DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA
RHA® is a trademark of TEOXANE SA.

Powering Aesthetic Practice and Patient Experiences

HintMD’s Integrated Platform

Transforms Revance Aesthetics Commercial Footprint

Reference: Data on File, IBIS, ISAPS, AmSpa